Beta3-adrenergic Receptors and Cardiovascular Function in Aging Women

Part of paid clinical trials in Columbia, Missouri.

Sponsor
University of Missouri-Columbia
Study ID
NCT07674680
Phase
EARLY_PHASE1
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 70 Years
Healthy Volunteers
Accepted

Interventions

  • Placebo — DRUG
    Participants will receive a placebo in pill form.
  • Gemtesa — DRUG
    Participants will receive oral gemtesa (75 mg).

Study Details

We hypothesize vascular beta3 adrenergic receptors are present and functional in aging women and can be targeted to attenuate sympathetic vasoconstriction and enhance vascular function in aging women.

Key Dates

Start date
Jul 31, 2026
Status verified
Jun 2026
Primary completion
May 31, 2028
Completion
May 31, 2029

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: Cold pressor test
    Participants will be exposed to the cold pressor test (ice water on the foot).
  • Experimental: Flow Mediated Dilation
    Participants will be exposed to the high-resolution ultrasound following inflation of a cuff around the forearm.

Primary Outcome Measure

Blood flow [ Time Frame: Change from baseline to minute 2. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of MissouriColumbiaMissouri65211
Jacqueline Limberg Associate Professor
[email protected]
1-573-882-2544

Find similar trials in Columbia, MO

By condition
Menopause
By specialty
Women's healthFertility
By research site
University of Missouri· Columbia, MO

Related Studies